ARCHIVES

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

This article is from The Cancer Letter archive.

Vol. 24 No. 42 | November 6, 1998

Download PDF Visit The Full Archive

Related Articles

In Brief: Use More Ad Hoc Committees For Grants, Look At Number, Distribution Of Centeres: Katterhagen

August 28, 1981

NCI Internal Debate Ends With Move of Biometry Branch, Including SEER, From DCCP To DRCCA

September 23, 1983

In Brief: Berlin Leaving Northwestern To Become Zubrod’s Deputy at Miami; Four Center Director Jobs Open

August 7, 1987

NIH Extramural Office Lists Initiatives For Reinvention

January 13, 1995

Tyrosine Kinase Inhibitor Encoraging For NSCLC

July 27, 2001

Latest U.S. cancer statistics cover 84% of population.

December 5, 2003